Condition: Acute Ischemic Stroke Patients · Sponsor: Southwest Hospital, China
The DATE-AGING study is a prospective, multicenter, randomized controlled trial investigating low-dose tenecteplase in elderly patients with acute ischemic stroke. Its primary objective is to evaluate the safety and efficacy of low-dose tenecteplase in elderly patients within 4.5 hours of acute ischemic stroke onset.
This description comes directly from the study's public registry record.
Hou Xianhua · 86-13594020663 · houxianhua@tmmu.edu.cn
Always discuss trial participation with your own doctor first.
| Southwest Hospital, Chongqing, China | Chongqing, Chongqing Municipality, China | Recruiting |
| Wuchang People's Hospital | Harbin, Heilongjiang, China | Recruiting |
| Shenqiu County People's Hospital | Zhoukou, Henan, China | Recruiting |
| Anshan Changda Hospital | Anshan, China | Not Yet Recruiting |
| Anyang People's Hospital | Anyang, China | Recruiting |
| Huaxian People's Hospital of Henan | Anyang, China | Recruiting |
| Baoshan People's Hospital | Baoshan, China | Not Yet Recruiting |
| People's Hospital of Zhijin County | Bijie, China | Not Yet Recruiting |
| Bishan Hospital | Chongqing, China | Not Yet Recruiting |
| Chongqing Emergency Medical Center | Chongqing, China | Recruiting |
| Chongqing University Fuling Hospital | Chongqing, China | Recruiting |
| Chongqing University Jiangjin Hospital | Chongqing, China | Recruiting |
+ 39 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07294209